These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2578907)

  • 1. Interpretation of the specificities of monoclonal antibodies recognising human MHC class II antigens.
    Guy K; Steel CM
    Clin Exp Immunol; 1985 Jan; 59(1):251-4. PubMed ID: 2578907
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA serology--1983.
    Grumet FC
    Prog Clin Biol Res; 1984; 149():207-20. PubMed ID: 6204338
    [No Abstract]   [Full Text] [Related]  

  • 3. The DA6-147 monoclonal antibody raised against the HLA-DR alpha chain identifies a cryptic epitope on the BoLA-DR alpha chain.
    Ababou A; Davis WC; Levy D
    Vet Res; 1993; 24(5):402-7. PubMed ID: 7505154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of autologous mixed lymphocyte reaction by monoclonal antibodies specific for the beta chain of HLA-DR antigens.
    Kasahara M; Ikeda H; Ogasawara K; Ishikawa N; Okuyama T; Fukasawa Y; Kojima H; Kunikane H; Hawkin S; Ohhashi T
    Immunology; 1984 Sep; 53(1):79-86. PubMed ID: 6205985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human helper and suppressor factors with special reference to HLA-DR determinants.
    Lehner T
    Immunology; 1983 Apr; 48(4):695-702. PubMed ID: 6187668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1D09C3, an mAb specific for MHC-II.
    Zola H; Beare A
    Curr Opin Mol Ther; 2008 Feb; 10(1):68-74. PubMed ID: 18228184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody to the HLA-DR product recognizes a polymorphic Ia determinant in mice.
    Brickell PM; McConnell I; Milstein C; Wright B
    Immunology; 1981 Jul; 43(3):493-501. PubMed ID: 6166548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody to a formaldehyde-resistant epitope on the nonpolymorphic constant part of the HLA-DR antigens.
    Sorg C; Bröcker EB; Zwadlo G; Redmann K; Feige U; Ax W; Feller AC
    Transplantation; 1985 Jan; 39(1):90-3. PubMed ID: 2578237
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas.
    Krajewski AS; Guy K; Dewar AE; Cossar D
    J Pathol; 1985 Feb; 145(2):185-94. PubMed ID: 2579225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The specificity of anti-HLA class II monoclonal antibodies in cattle.
    Nilsson PR; Marsh SG; Joosten I; Nieuwland MG; Hensen EJ; Grosfeld-Stulemeyer MC; Mikko S; Gelhaus A; Schreuder GM
    Eur J Immunogenet; 1997 Jun; 24(3):211-23. PubMed ID: 9226127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
    Guy K; Meehan RR; Dewar AE; Larhammar D
    Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of human antigen-specific T cell clone proliferative responses by distinct monoclonal anti-HLA-DR antibodies.
    Triebel F; Missenard-Leblond V; Couty MC; Charron DJ; Debre P
    J Immunol; 1984 Apr; 132(4):1773-8. PubMed ID: 6199412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monoclonal antibodies specific to cell surface antigens of human lymphocytes].
    Ikeda H
    Rinsho Byori; 1983 Mar; 31(3):239-45. PubMed ID: 6408286
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of primate islets with anti-class II antibodies and complement fails to deplete class II-bearing cells.
    Flynn GJ; Leow CK; Sutton RS; Gray DW; Morris PJ
    Transplant Proc; 1990 Apr; 22(2):786-8. PubMed ID: 2109402
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of antigenic determinants on human myeloid colony forming cells with monoclonal antibodies.
    Greenberg P; Grossman M; Charron D; Levy R
    Exp Hematol; 1981 Aug; 9(7):781-7. PubMed ID: 6172283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.